Denintuzumab (Synonyms: hBU 12) |
| Catalog No.GC68962 |
Denintuzumab (hBU 12) is a recombinant humanized monoclonal antibody against CD19. Denintuzumab can be used as the antibody portion of an antibody-drug conjugate (ADC), which is synthesized as Denintuzumab Mafodotin (SGN-CD19A). Denintuzumab Mafodotin can be used for research on acute lymphocytic leukemia.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1630074-14-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Denintuzumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Denintuzumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *